<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The presence of Epstein-Barr virus (EBV) DNA in biopsies of human <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> was tested by complementary <z:chebi fb="40" ids="33697">RNA</z:chebi> (cRNA) hybridization on membranes and DNA-DNA reassociation kinetics </plain></SENT>
<SENT sid="1" pm="."><plain>DNA-DNA reassociation kinetics can detect as few as 1 EBV genome in every 50 cells, and the cRNA method can detect EBV genomes if 2 or more are present in a cell </plain></SENT>
<SENT sid="2" pm="."><plain>Twenty-three out of 24 African Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> biopsies, 18 out of 23 African nasopharyngeal <z:mp ids='MP_0002038'>carcinomas</z:mp> (NPC), and 8 out of 24 other African <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> were positive for EBV DNA </plain></SENT>
<SENT sid="3" pm="."><plain>Three cases of American Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> were tested by the cRNA method, and EBV DNA was not detected </plain></SENT>
<SENT sid="4" pm="."><plain>Three out of 25 American <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> other than American Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> contained 0.1 to 0.3 genomes per cell of EBV DNA </plain></SENT>
</text></document>